Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2018-08-21 Earnings Release
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
2018年度前三季度业绩预告
Earnings Release Classification · 95% confidence The document is a performance forecast for the first three quarters of 2018, including estimated net profit and earnings per share for the period January 1 to September 30, 2018, and specifically for the third quarter July 1 to September 30, 2018. It explicitly states it is a '业绩预告' (performance forecast) and mentions that the detailed financial data will be disclosed in the third quarter financial report. The document length is 2335 characters, which is relatively short and primarily provides forecasted financial results rather than actual financial statements or detailed analysis. It is not a full interim or quarterly report but a preliminary earnings guidance announcement. Therefore, the document fits best into the Earnings Release (ER) category, which covers initial announcements of quarterly or periodical financial results with key highlights only. 9M 2018
2018-08-21 Chinese
第八届监事会第七次会议决议公告
Report Publication Announcement Classification · 95% confidence The document is a resolution announcement from the Supervisory Board meeting of a company, specifically approving the 2018 semi-annual report summary and full text. It states that the report was prepared and reviewed according to legal and regulatory requirements and that the report content is accurate and complete. However, the document itself does not contain the actual financial statements or substantive financial data but rather announces the approval and references the report published elsewhere. The document length is short (911 characters), and it serves as an announcement of the report's approval and publication rather than the report itself. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA) rather than an Interim/Quarterly Report (IR).
2018-08-21 Chinese
第八届董事会第十三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 13th meeting of the 8th Board of Directors of the company. It includes voting results on several agenda items such as approval of the 2018 semi-annual report summary and full text, approval of equity transfer and related party transactions, and approval of absorption merger among wholly-owned subsidiaries. The document does not contain the actual semi-annual report or detailed financial statements but refers to the report being disclosed elsewhere (e.g., newspapers and company website). The document is primarily a board meeting resolution announcement, not the report itself. Therefore, it fits best under Board/Management Information (MANG). The document length is short (1695 characters), and it is an announcement of board decisions rather than a full financial report or detailed management discussion.
2018-08-21 Chinese
2018年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "成都市贝瑞和康基因技术股份有限公司 2018 年半年度报告全文" which translates to "Berry Genomics Co., Ltd. 2018 Semi-Annual Report Full Text." It contains detailed financial data, business overview, management discussion and analysis, and other comprehensive information typical of a semi-annual or interim financial report. The document includes financial figures for the first half of 2018, comparisons with the previous year, detailed business descriptions, and risk disclosures. It is not a brief announcement or a presentation but a full report with substantive financial data and analysis for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2018
2018-08-21 Chinese
关于全资子公司之间吸收合并的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the absorption merger between wholly-owned subsidiaries of the company. It details the merger plan, approval by the board, basic information about the merging entities, financial data of the subsidiaries, and the impact of the merger. It is a corporate action announcement related to restructuring within subsidiaries, not a financial report or earnings release. There is no indication of a full annual or interim report, audit report, or earnings release. The document is a formal announcement of a corporate restructuring event, specifically a merger between subsidiaries, which fits best under Capital/Financing Update (CAP) as it relates to changes in company structure and capital organization. The document length is substantial and contains detailed financial data of the subsidiaries, but it is not a financial report itself. Therefore, the classification is CAP with high confidence.
2018-08-21 Chinese
独立董事关于有关事项的独立意见
Audit Report / Information Classification · 95% confidence The document is an independent opinion from independent directors regarding related party transactions, specifically about the transfer of equity in a subsidiary and the company's external guarantees. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange listing rules concerning related party transactions. The document provides detailed independent opinions and approvals related to a specific transaction rather than a general management or board change announcement. It is not a full annual or interim report, nor is it a simple announcement or certification. The content fits best with a specialized report on audit or related party transaction matters, which aligns with the Audit Report / Information (AR) category, as it involves independent directors' opinions on compliance and fairness of a related party transaction and financial guarantees. The document length is short and focused on a specific audit-related opinion rather than a full report or announcement. Therefore, the classification is AR with high confidence. H1 2018
2018-08-21 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.